Link：
Shenzhen B2go Technology Company Limited
: Guidance on how the EMA monitors literature for certain active substances, reducing the duplicative workload for MAHs.
: Instructions for performing "duplicate checks" to avoid redundant entries when the same case appears in multiple databases or journals.
The document provides a structured workflow for processing adverse drug reaction (ADR) data:
: Clear identification of the substance or medicinal product involved.
: Specific details like gender or age must be present.
